Craig Hettenbach

Stock Analyst at Morgan Stanley

(2.66)
# 2,198
Out of 5,090 analysts
302
Total ratings
57.04%
Success rate
-0.77%
Average return

Stocks Rated by Craig Hettenbach

Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22$12
Current: $8.79
Upside: +36.52%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57$67
Current: $50.04
Upside: +33.89%
Veeva Systems
Aug 28, 2025
Maintains: Underweight
Price Target: $210$222
Current: $242.00
Upside: -8.26%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157$144
Current: $141.51
Upside: +1.76%
HCA Healthcare
Jul 28, 2025
Maintains: Equal-Weight
Price Target: $410$400
Current: $486.70
Upside: -17.81%
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $17.49
Upside: +42.94%
Hims & Hers Health
Jun 11, 2025
Reiterates: Equal-Weight
Price Target: $40
Current: $39.20
Upside: +2.04%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175$210
Current: $210.00
Upside: -
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $231.08
Upside: -13.45%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20$11
Current: $4.01
Upside: +161.85%
Maintains: Equal-Weight
Price Target: $7$6
Current: $2.71
Upside: +121.40%
Maintains: Equal-Weight
Price Target: $9$5
Current: $2.46
Upside: +103.25%
Maintains: Equal-Weight
Price Target: $96$114
Current: $69.32
Upside: +64.45%
Maintains: Overweight
Price Target: $62$57
Current: $33.55
Upside: +69.90%
Maintains: Overweight
Price Target: $85$81
Current: $65.81
Upside: +23.08%
Maintains: Equal-Weight
Price Target: $55$35
Current: $45.93
Upside: -23.80%
Maintains: Overweight
Price Target: $20$18
Current: $16.77
Upside: +7.33%
Maintains: Overweight
Price Target: $208$185
Current: $89.96
Upside: +105.65%
Maintains: Equal-Weight
Price Target: $162$167
Current: $234.36
Upside: -28.74%
Maintains: Equal-Weight
Price Target: $42$42
Current: $139.36
Upside: -69.86%
Maintains: Equal-Weight
Price Target: $165$159
Current: $182.51
Upside: -12.88%
Maintains: Overweight
Price Target: $115$125
Current: $75.63
Upside: +65.28%
Maintains: Overweight
Price Target: $57$72
Current: $390.24
Upside: -81.47%
Maintains: Underweight
Price Target: $193$195
Current: $182.54
Upside: +6.83%
Maintains: Overweight
Price Target: $515$488
Current: $330.91
Upside: +47.47%
Maintains: Overweight
Price Target: $297$296
Current: $151.86
Upside: +94.92%
Maintains: Overweight
Price Target: $273$368
Current: $258.39
Upside: +42.42%
Maintains: Overweight
Price Target: $500$513
Current: $257.85
Upside: +98.95%
Maintains: Overweight
Price Target: $321$275
Current: $265.44
Upside: +3.60%
Maintains: Overweight
Price Target: $94$88
Current: $38.34
Upside: +129.53%
Upgrades: Equal-Weight
Price Target: n/a
Current: $54.74
Upside: -
Maintains: Overweight
Price Target: $173$185
Current: $77.57
Upside: +138.49%
Downgrades: Equal-Weight
Price Target: $190$213
Current: $227.95
Upside: -6.56%
Maintains: Equal-Weight
Price Target: $53$58
Current: $158.26
Upside: -63.35%
Maintains: Equal-Weight
Price Target: $101$117
Current: $281.29
Upside: -58.41%